Aimei Health Technology Co Ltd (AFJK) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AFJK Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Aimei Health Technology Co Ltd balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Other Current Assets0.00
Prepaid Expense, Current AS0.04
Total Current Assets0.04
Other Assets, Noncurrent12.49
Total Assets12.53
Liabilities
Accrued Liabilities, Current AC0.51
Other Short-term Borrowings SH2.20
Other Liabilities, Current1.13
Total Current Liabilities3.84
Total Long-term Debt0.00
Deferred Compensation Liability, Classified, Noncurrent LI0.69
Other liabilities, Noncurrent0.00
Total Liabilities4.53
Stockholders' Equity
Common Stock Value0.00
Retained Earnings / Accumulated Deficit-4.48
Other Equity0.00
Common Stockholder's Equity-16.97
Non-controlling interests & other12.49
Total Stockholder's Equity-4.48
Liabilities & Stockholder's Equity12.53
4 historic quarters locked

Sign in to unlock the full Aimei Health Technology Co Ltd balance sheet history.

About Aimei Health Technology Co Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 13, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-037588

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.